Rhythm Pharmaceuticals buy Royal Bank of Canada
Start price
17.03.26
/
50%
€77.50
Target price
17.03.27
€113.07
Performance (%)
5.16%
Price
09:32
?
Summary
This prediction is currently active. With a performance of 5.16%, the BUY prediction by Royal_Bank_of_Canada for Rhythm Pharmaceuticals is trending in the right direction. This prediction currently runs until 17.03.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 17.391% | 17.391% |
| iShares Core DAX® | 0.423% | 5.706% |
| iShares Nasdaq 100 | 4.096% | 16.639% |
| iShares Nikkei 225® | 4.469% | 18.343% |
| iShares S&P 500 | 1.788% | 9.644% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Royal Bank Of Canada from $140.00 to $130.00. They now have an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€81.00
06.05.26
06.05.26
€116.89
06.05.27
06.05.27
0.62%
09:32
09:32
